Low-Dose Tissue Plasminogen Activator and Standard-Dose Tissue Plasminogen Activator in Acute Ischemic Stroke in Asian Populations: A Review

Publisher： Karger

E-ISSN： 1421-9786|36|3|161-166

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.36, Iss.3, 2013-10, pp. : 161-166

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Eligibility for Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke

By  

Cerebrovascular Diseases, Vol. 22, Iss. 5-6, 2006-11 ,pp. : 423-428

Karger

Access to resources Recommend Favorite

Intravenous Tissue Plasminogen Activator for an Ischemic Stroke with Occult Double Primary Cancer

By  

Case Reports in Neurology, Vol. 6, Iss. 3, 2014-10 ,pp. : 238-242

Karger

Access to resources Recommend Favorite

Utilization of Intravenous Tissue Plasminogen Activator for Ischemic Stroke: Are There Sex Differences?

By  

Cerebrovascular Diseases, Vol. 27, Iss. 3, 2009-01 ,pp. : 254-258

Karger

Access to resources Recommend Favorite

Repeated Intravenous Treatment with Recombinant Tissue-Type Plasminogen Activator in Patients with Acute Ischemic Stroke

By  

European Neurology, Vol. 74, Iss. 3-4, 2015-09 ,pp. : 127-134

Karger

Access to resources Recommend Favorite

Intravenous Tissue Plasminogen Activator for Acute Stroke in California: Recipients and Resources

By  

Cerebrovascular Diseases, Vol. 17, Iss. 4, 2004-05 ,pp. : 341-343

Karger

Access to resources Recommend Favorite